Results 311 to 320 of about 1,360,599 (360)
Some of the next articles are maybe not open access.

Tumours

Neurological Sciences, 2008
Detection of a brain lesion is the first diagnostic step in patients with symptoms and signs suggesting the presence of a brain tumour. Imaging is primarily done to prove or rule out the presence of such a lesion. The first diagnostic evaluation is based on neuroradiological imaging, and when the diagnosis of brain tumour is highly suspicious, the type
FALINI A   +2 more
openaire   +4 more sources

Tumour-promoting and Tumour-inhibiting Fractions from Tumours

Nature, 1966
RELATIVELY simple preparatory procedures reported from our laboratories1 have been extended to obtain tumour-promoting fractions (MF1 and MF2) and a tumour-inhibiting fraction from lyophilized ascites sarcoma 37 (carried in BT mice) and dbrB adenocarcinoma (carried in DBA/1 mice).
Mamola, N J, Cook, E S
openaire   +2 more sources

Tumours and Tumour-Like Lesions

2003
Bone sarcomas are uncommon when compared with other malignancies, accounting for only 0.2% of all tumours (Dorfman and Czerniak 1995). Their incidence is approximately one-tenth that of soft tissue sarcomas (Mack 1995) and one-sixtieth that of either lung or breast carcinoma. The annual incidence for bone sarcomas is approximately 0.8/1 00,000 (Dorfman
D. A. Ritchie, A. M. Davies, D. Vanel
openaire   +2 more sources

Oligoclonal tumours

International Journal of Cancer, 1986
AbstractTumours are commonly classified as monoclonal or polyclonal. The question of how many clones are present in a polyclonal tumour is seldom asked; it is important, however, because the answer may show whether or not clones arise and develop independently, and whether the number of clones in tumours of a particular kind tends to increase or ...
M F, Woodruff   +3 more
openaire   +2 more sources

Vascular tumours

Clinical and Experimental Dermatology
This study discusses the diagnostic and therapeutic complexities of a rare vascular tumour. Utilizing FOSB staining as a diagnostic tool, we illustrate its efficacy through a detailed case presentation. Additionally, we explore innovative therapeutic approaches, including targeted therapies that have shown promising results, thereby potentially ...
Fuminori Katsumata   +3 more
openaire   +2 more sources

Tumours and Tumour-like Lesions

1978
The spectrum of tissues to be found in different parts of the mouth includes keratinizing and non-keratinizing epithelium, a variety of mesodermal components ranging from bone to lymphoid tissue, and a rich salivary tissue component. Therefore, the majority of the neoplasms arising from the oral tissues have exact counterparts in other regions of the ...
openaire   +2 more sources

Urethral Tumours

British Journal of Urology, 1978
Summary— A series of 33 patients with urethral tumours has been studied to asess the risk of dissemination by endoscopic diathermy. This risk is less than that of cystourethrectomy. Urethral tumours should be treated like the vesical tumours they follow and so closely resemble: by endoscopic treatment while they
P A, Stewart   +3 more
openaire   +2 more sources

Desmoid tumours

European Journal of Surgical Oncology (EJSO), 2001
Desmoid tumours exhibit fibroblastic proliferation and arise from fascial or musculoaponeurotic structures. Despite their benign microscopic appearance, and their negligible metastatic potential, the propensity of desmoid tumours for local infiltration is potentially significant in terms of deformity, morbidity and mortality due to pressure effects and
C J, Shields   +3 more
openaire   +2 more sources

Carcinoid tumour

The Lancet, 1998
Carcinoid tumours are often indolent asymptomatic tumours. However, a small but significant proportion are malignant and difficult to manage. Multiple endocrine neoplasia type 1 (MEN-1) may be associated with carcinoid tumours and should therefore be considered in the investigation of these patients.
M E, Caplin   +5 more
openaire   +2 more sources

Clinical relevance of tumour-associated macrophages

Nature Reviews Clinical Oncology, 2022
Mikael J Pittet, Denis Migliorini
exaly  

Home - About - Disclaimer - Privacy